Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-104169
Filing Date
2017-03-30
Accepted
2017-03-30 16:34:58
Documents
80
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d327055d10k.htm 10-K 1158128
2 EX-23.1 d327055dex231.htm EX-23.1 1445
3 EX-31.1 d327055dex311.htm EX-31.1 5944
4 EX-31.2 d327055dex312.htm EX-31.2 5889
5 EX-32.1 d327055dex321.htm EX-32.1 4172
12 GRAPHIC g327055g20x69.jpg GRAPHIC 79504
13 GRAPHIC g327055g57s99.jpg GRAPHIC 95650
14 GRAPHIC g327055g73s66.jpg GRAPHIC 74941
  Complete submission text file 0001193125-17-104169.txt   5249088

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT drna-20161231.xml EX-101.INS 814189
7 XBRL TAXONOMY EXTENSION SCHEMA drna-20161231.xsd EX-101.SCH 52022
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20161231_cal.xml EX-101.CAL 67847
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20161231_def.xml EX-101.DEF 160120
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20161231_lab.xml EX-101.LAB 449970
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20161231_pre.xml EX-101.PRE 311396
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36281 | Film No.: 17726206
SIC: 2834 Pharmaceutical Preparations